NovoLog Mix-vs.-Exenatide Study Group
All authors
About
Publications While At HealthPartners
selected publications
Journal Article
Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea
.
Current Medical Research and Opinion.
2009
Contact
full name
NovoLog Mix-vs.-Exenatide Study Group
Quick Info
Collaboration
Co-author network
Map of science